Search Ontology:
ChEBI
ZSTK-474
- Term ID
- CHEBI:90545
- Synonyms
-
- 1-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1H-benzimidazole
- 2-(2-difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine
- 2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
- 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole
- 4,4'-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine
- ZSTK 474
- ZSTK474
- Definition
- A triamino-1,3,5-triazine that is 1,3,5-triazine in which two of the hydrogens have been replaced by morpholin-4-yl groups while the third hydrogen has been replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is an inhibitor of phosphatidylinositol 3-kinase.
- References
-
- cas:475110-96-4
- lincs.smallmolecule:LSM-1053
- pdb-ccd:ZS4
- pubmed:16622124
- pubmed:17711503
- pubmed:19094964
- pubmed:19144509
- pubmed:19182393
- pubmed:20081827
- pubmed:20482767
- pubmed:20729870
- pubmed:21352422
- pubmed:21993922
- pubmed:22088482
- pubmed:22349137
- pubmed:23812078
- pubmed:24204196
- pubmed:24297065
- pubmed:24821574
- pubmed:24844601
- pubmed:25483727
- pubmed:26081844
- reaxys:11677260
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from ZSTK-474
Phenotype where environments contain ZSTK-474
Phenotype modified by environments containing ZSTK-474
Phenotype affecting ZSTK-474
Human Disease Model